标题
Management of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients
作者
关键词
Olanzapine, Ondansetron, Granisetron, Aprepitant, Palonosetron
出版物
PEDIATRIC DRUGS
Volume 19, Issue 3, Pages 213-222
出版商
Springer Nature
发表日期
2017-04-21
DOI
10.1007/s40272-017-0228-2
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The Safety of Prochlorperazine in Children: A Systematic Review and Meta-Analysis
- (2016) Melissa Lau Moon Lin et al. DRUG SAFETY
- The Safety of Metoclopramide in Children: A Systematic Review and Meta-Analysis
- (2016) Melissa Lau Moon Lin et al. DRUG SAFETY
- Palonosetron versus ondansetron for prevention of chemotherapy-induced nausea and vomiting in paediatric patients with cancer receiving moderately or highly emetogenic chemotherapy: a randomised, phase 3, double-blind, double-dummy, non-inferiority study
- (2016) Gábor Kovács et al. LANCET ONCOLOGY
- Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting
- (2016) Rudolph M. Navari et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting
- (2016) Rudolph M. Navari et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guideline for the Treatment of Breakthrough and the Prevention of Refractory Chemotherapy-Induced Nausea and Vomiting in Children With Cancer
- (2016) Jacqueline Flank et al. PEDIATRIC BLOOD & CANCER
- 2016 updated MASCC/ESMO consensus recommendations: Prevention of acute chemotherapy-induced nausea and vomiting in children
- (2016) L. Lee Dupuis et al. SUPPORTIVE CARE IN CANCER
- Rolapitant for the treatment of chemotherapy-induced nausea and vomiting
- (2015) Rudolph M Navari Expert Review of Anticancer Therapy
- Survival of patients with metastatic breast cancer with or without locoregional therapy
- (2015) Ioannis Gounaris LANCET ONCOLOGY
- Aprepitant and Fosaprepitant: A 10-Year Review of Efficacy and Safety
- (2015) M. Aapro et al. ONCOLOGIST
- Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial
- (2015) Sameer Bakhshi et al. SUPPORTIVE CARE IN CANCER
- Evidence to support use of palonosetron over generic serotonin type 3-receptor antagonists for chemotherapy-induced nausea and vomiting
- (2014) Y.-C. Yeh et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- The Safety of Olanzapine in Young Children: A Systematic Review and Meta-Analysis
- (2014) Jacqueline Flank et al. DRUG SAFETY
- Palonosetron for the treatment of chemotherapy-induced nausea and vomiting
- (2014) Rudolph M Navari EXPERT OPINION ON PHARMACOTHERAPY
- Olanzapine for treatment and prevention of acute chemotherapy-induced vomiting in children: A retrospective, multi-center review
- (2014) Jacqueline Flank et al. PEDIATRIC BLOOD & CANCER
- Ondansetron and the Risk of Cardiac Arrhythmias: A Systematic Review and Postmarketing Analysis
- (2013) Stephen B. Freedman et al. ANNALS OF EMERGENCY MEDICINE
- Management of Chemotherapy-Induced Nausea and Vomiting
- (2013) Rudolph M. Navari DRUGS
- The current status of the use of palonosetron
- (2013) Rudolph Navari EXPERT OPINION ON PHARMACOTHERAPY
- Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients
- (2013) L. Lee Dupuis et al. PEDIATRIC BLOOD & CANCER
- Lorcaserin: An investigational serotonin 2C agonist for weight loss
- (2011) K. M. Hurren et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Single-Dose Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated With Cisplatin Therapy: Randomized, Double-Blind Study Protocol—EASE
- (2011) Steven Grunberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients
- (2011) L. Lee Dupuis et al. PEDIATRIC BLOOD & CANCER
- Reduced Ghrelin Secretion in the Hypothalamus of Rats due to Cisplatin-Induced Anorexia
- (2010) Koji Yakabi et al. ENDOCRINOLOGY
- Antiemetics in children receiving chemotherapy. MASCC/ESMO guideline update 2009
- (2010) Karin Jordan et al. SUPPORTIVE CARE IN CANCER
- Palonosetron triggers 5-HT3 receptor internalization and causes prolonged inhibition of receptor function
- (2009) Camilo Rojas et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started